Prevention of iron deficiency and iron deficiency anemia in therapeutic practice
https://doi.org/10.51793/OS.2025.28.11.012
Abstract
Background. The problem of iron deficiency and iron deficiency anemia as its severe manifestation is urgent due to its prevalence, clinical, social and economic significance. World Health Organization experts regard anemia not only as a disease, but also as a public health problem and identify a number of socio-economic factors as the cause of anemia: education level, financial capabilities, access to medical care, quality and food safety. Despite attempts by the world community to reduce the incidence of anemia in a group of women of reproductive age, the prevalence of anemia is not decreasing. Demographic changes towards an increase in the proportion of elderly people lead to the formation of a new risk group, for which a decrease in hemoglobin is associated with an unfavorable prognosis for health and life. The most common anemia in all categories of patients is iron deficiency anemia, the leading cause of which is considered to be iron deficiency in the diet. Diagnosis of anemia is based primarily on laboratory parameters. A decrease in hemoglobin levels below 130 g/L in men and 120 g/L in women is the main criterion for anemia. To confirm GI and differential diagnosis with other anemias, it is necessary to evaluate iron metabolism indicators - ferritin, iron transferrin saturation ratio, total iron-binding capacity of serum and transferrin.
Results. To prevent iron deficiency, as well as other deficiency conditions, it is necessary to implement individual and population preventive measures. This was dedicated to the Council of Experts, held 15.04.2025 in Moscow. It should be noted that this event was an important step in terms of organizational and clinical decisions for the possibility of implementing the World Health Organization program to reduce the burden of anemia in our country.
About the Authors
N. O. Khovasova
N. I. Pirogov Russian National Research Medical University
Россия
Россия
Natalya O. Khovasova, Dr. of Sci. (Med.), Professor of the Department of Ageing Diseases, Institute of Continuing Education and Professional Development; Senior Researcher of the Musculoskeletal system diseases laboratory
1 Ostrovityanova str., Moscow, 117513
A. V. Naumov
N. I. Pirogov Russian National Research Medical University
Россия
Россия
Anton V. Naumov, Dr. of Sci. (Med.), Professor of the Department of Ageing Diseases, Institute of Continuing Education and Professional Development; Head of the Musculoskeletal system diseases laboratory
1 Ostrovityanova str., Moscow, 117513
References
1. Passarelli S., Free C. M., Shepon A., et al. Global estimation of dietary micronutrient inadequacies: a modelling analysis. Lancet Glob Health. 2024; 12 (10): e1590-e1599. DOI: 10.1016/S2214-109X(24)00276-6.
2. Zimmermann M. B., Hurrell R. F. Nutritional iron deficiency. Lancet. 2007; 370 (9586): 511-520. DOI: 10.1016/S0140-6736(07)61235-5.
3. Teh M. R., Armitage A. E., Drakesmith H. Why cells need iron: a compendium of iron utilisation. Trends Endocrinol Metab. 2024; 35 (12): 1026-1049. DOI: 10.1016/j.tem.2024.04.015.
4. Schrage B., Rübsamen N., Schulz A., et al. Iron deficiency is a common disorder in general population and independently predicts all-cause mortality: results from the Gutenberg Health Study. Clin Res Cardiol. 2020; 109 (11): 1352-1357. DOI: 10.1007/s00392-020-01631-y.
5. WHO, Chan M. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva, Switz World Heal Organ [Internet]. 2011; 1-6.
6. GBD 2021 Anaemia Collaborators. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet Haematol. 2023; 10 (9): e713-e734. DOI: 10.1016/S2352-3026(23)00160-6.
7. Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO.
8. Atkinson S. H., Suchdev P. S., Bode M., et al. Getting back on track to meet global anaemia reduction targets: a Lancet Haematology Commission. Lancet Haematol. 2025; 12 (9): e717-e767. DOI: 10.1016/S2352-3026(25)00146-2.
9. Khovasova N. O., Vorobyova N. M., Tkacheva O. N., et al. Prevalence of anemia and its association with other geriatric syndromes in individuals over 65 years of age: data from the Russian epidemiological study EVKALIPT. Terapevticheskii arkhiv. 2022; 94 (1): 24-31. DOI: 10.26442/00403660.2022.01.201316. (In Russ.)
10. Prevalence of anaemia, iron, and vitamin deficiencies in the health system in the Republic of Ireland: a retrospective cohort study Conor Cian Clancy, Leonard D Browne, Robert Gilligan, Ophelia Blake and Austin G Stack BJGP Open 2024; 8 (2): BJGPO.2023.0126. DOI: https://DOI.org/10.3399/BJGPO.2023.0126.
11. Lee C. T., Chen M. Z., Yip C. Y. C., et al. Prevalence of Anemia and Its Association with Frailty, Physical Function and Cognition in Community- Dwelling Older Adults: Findings from the HOPE Study. J Nutr Health Aging. 2021; 25 (5): 679-687. DOI: 10.1007/s12603-021-1625-3.
12. Corona L. P., Oliveira G. B., Fernandes L. V., et al. Interrelationships of frailty, hemoglobin, cognition, and depressive symptoms in aging: a path analysis of the ELSI-Brazil study. Cad Saude Publica. 2025; 41 (3): e00105124. DOI: 10.1590/0102-311XEN105124.
13. Amano S., Ohta R., Sano C. Relationship between Anemia and Readmission among Older Patients in Rural Community Hospitals: A Retrospective Cohort Study. J Clin Med. 2024; 13 (2): 539. DOI: 10.3390/jcm13020539.
14. Morita Y., Ito H., Kawaguchi S., et al. Systemic chronic diseases coexist with and affect locomotive syndrome: The Nagahama Study. Mod Rheumatol. 2023; 33 (3): 608-616. DOI: 10.1093/mr/roac039.
15. Duh M. S., Mody S. H., Lefebvre P., et al. Anaemia and the risk of injurious falls in a community-dwelling elderly population. Drugs Aging. 2008; 25 (4): 325-334. DOI: 10.2165/00002512-200825040-00005. PMID: 18361542.
16. Xu B., Guo Z., Jiang B., et al. Factors affecting sarcopenia in older patients with chronic diseases. Ann Palliat Med. 2022; 11 (3): 972-983. DOI: 10.21037/apm-22-201.
17. Graham F. J., Friday J. M., Pellicori P., et al. Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease. Heart. 2023; 109 (17): 1294-1301. DOI: 10.1136/heartjnl-2022-32214.
18. Khovasova N. O., Vorobyova N. M., Naumov A. V., et al. The effect of anemia on the 5-year survival rate of elderly people and centenarians. Lechebnoe delo. 2022; 2: 22-36. (In Russ.)
19. Köseoğlu F. D., Özlek B. Anemia and Iron Deficiency Predict All-Cause Mortality in Patients with Heart Failure and Preserved Ejection Fraction: 6-Year Follow-Up Study. Diagnostics (Basel). 2024; 14 (2): 209.
20. Pasricha S. R., Rogers L., Branca F., Garcia-Casal M. N. Measuring haemoglobin concentration to define anaemia: WHO guidelines. Lancet. 2024; 403 (10440): 1963-1966. DOI: 10.1016/S0140-6736(24)00502-6.
21. Haider L. M., Schwingshackl L., Hoffmann G., Ekmekcioglu C. The effect of vegetarian diets on iron status in adults: A systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition. 2026; 58 (8): 1359-1374. https://DOI.org/10.1080/10408398.2016.1259210.
22. Lesjak M., Hoque R., Balesaria S., et al. Quercetin Inhibits Intestinal Iron Absorption and Ferroportin Transporter Expression In Vivo and In Vitro. PLoS ONE 2014; 9 (7): e102900. https://DOI.org/10.1371/journal.pone.0102900.
23. Liu X. Association between dietary inflammation index with anemia in Americans: a cross-sectional study with U.S. National health and nutrition examination survey. Hematology. 2024; 29 (1): 2337567. DOI: 10.1080/16078454.2024.2337567.
24. Cao N., Li J., Ling C., Wang J., An F. The association between dietary inflammatory index and anemia in individuals with diabetes mellitus. Front Nutr. 2025; 12: 1538696. DOI: 10.3389/fnut.2025.1538696.
25. Kolarš B., Mijatović Jovin V., Živanović N., et al. Iron Deficiency and Iron Deficiency Anemia: A Comprehensive Overview of Established and Emerging Concepts. Pharmaceuticals (Basel). 2025; 18 (8): 1104. DOI: 10.3390/ ph18081104.
26. Giromini C., Givens D. I. Benefits and Risks Associated with Meat Consumption during Key Life Processes and in Relation to the Risk of Chronic Diseases. Foods. 2022; 11 (14): 2063. DOI: 10.3390/foods11142063.
27. Berger M. M., Shenkin A., Dizdar O. S., et al. ESPEN practical short micronutrient guideline. Clin Nutr. 2024; 43 (3): 825-857. DOI: 10.1016/j.clnu.2024.01.030.
28. Clinical guidelines "Malnutrition in elderly and senile patients" 2025. https://cr.minzdrav.gov.ru/view-cr/615_3. (In Russ.)
29. Blank P. R., Tomonaga Y., Szucs T. D., et al. Economic burden of symptomatic iron deficiency – a survey among Swiss women. BMC Women's Health. 2019; 19: 39. https://DOI.org/10.1186/s12905-019-0733-2.
30. Munro M. G., Critchley H. O., Broder M. S., Fraser I. S. FIGO Working Group on Menstrual Disorders. FIGO classification system (PALMCOEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011; 113 (1): 3-13. DOI: 10.1016/j.ijgo.2010.11.011.
31. Taylor H. S., Pal L., Sell E. Speroff’s Clinical Gynecologic Endocrinology and Infertility. 9th ed. Wolters Kluwer; Philadelphia, PA, USA: 2020.
32. Singh S. S., Calaf Alsina J., Vannuccini S., et al. Clinical perspectives on the menstrual pictogram for the assessment of heavy menstrual bleeding. Hum Reprod Open. 2022; 2022 (4): hoac048. DOI: 10.1093/hropen/hoac04.
33. Sokolovskaya T. A., Bantieva M. N. Dynamics of somatic morbidity in women complicating childbirth. Social aspects of public health [online publication] 2022; 68 (1): 11. URL: http://vestnik.mednet.ru/content/view/1345/30/lang,ru/ DOI: 10.21045/2071-5021-2022-68-1-11. (In Russ.)
34. Clinical guidelines "Iron deficiency anemia" 2024. https://cr.minzdrav.gov.ru/view-cr/669_2. (In Russ.)
35. Ali Daud Mohammad. Proton Pump Inhibitors’ Use and Risk of Iron Deficiency Anaemia: A Systematic Review and Meta-analysis, Current Reviews in Clinical and Experimental Pharmacology 2023; 18 (2). https://dx.DOI.org/10.2174/2772432817666220307121220.
36. Wu Y. T., Lu Y. T., Chu C. Y., et al. Is use of a long-term proton pump inhibitor or histamine-2 receptor antagonist a risk factor for iron-deficiency anaemia in Taiwan? A neglected clinical drug-drug interaction. Fam Pract. 2025; 42 (2): cmad090. DOI: 10.1093/fampra/cmad090.
37. Zhou H., Fan Z., Da Y., et al. Causal Relationships Between Iron Deficiency Anemia, Gut Microbiota, and Metabolites: Insights from Mendelian Randomization and In Vivo Data. Biomedicines. 2025; 13 (3): 677. DOI: 10.3390/biomedicines13030677.
38. Soriano-Lerma A., García-Burgos M., Barton W., et al. Comprehensive insight into the alterations in the gut microbiome and the intestinal barrier as a consequence of iron deficiency anaemia. Biomed J. 2024: 100701. DOI: 10.1016/j.bj.2024.100701.
39. Özbilen M. Coexistence of multiple causes in patients with iron deficiency. Eur Rev Med Pharmacol Sci. 2024; 28 (2): 469-476. DOI: 10.26355/eurrev_202401_35046.
40. Lahtiharju T., Savola P., Lempiäinen A., et al. Ferritin outperforms other biomarkers in predicting bone marrow iron stores in patients with hematologic disorders. Blood Adv. 2025; 9 (7): 1608-1617. DOI: 10.1182/bloodadvances.2024014283.
41. Nutritional anaemias: tools for effective prevention and control. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.
42. Drapkina O. M., Tkacheva O. N., Shikh E. V., Drozdova L. Yu., Baranov I. I., Bakulin I. G., Bakirov B. A., Ponomarev R. V., Starodubova A. V., Fedorova T. A., Khovasova N. O. Prevention of iron deficiency and iron deficiency anemia in various categories of patients in the Russian Federation. Resolution of the Council of Experts. Pervichnaya medikosanitarnaya pomosch. 2025;2(3):21-34. doi: 10.15829/3034-4123-2025-74. EDN: WZJVAX
43. Yu X., Chen L., Ding H., et al. Iron Transport from Ferrous Bisglycinate and Ferrous Sulfate in DMT1-Knockout Human Intestinal Caco-2 Cells. Nutrients. 2019; 11 (3): 485. DOI: 10.3390/nu11030485.
44. Bumrungpert A., Pavadhgul P., Piromsawasdi T., Mozafari M. R. Efficacy and Safety of Ferrous Bisglycinate and Folinic Acid in the Control of Iron Deficiency in Pregnant Women: A Randomized, Controlled Trial. Nutrients. 2022; 14 (3): 452. DOI: 10.3390/nu14030452. PMID: 35276810; PMCID: PMC8839493.
45. Milman N., Jønsson L., Dyre P., et al. Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial. J Perinat Med. 2014; 42 (2): 197-206. DOI: 10.1515/jpm-2013-0153. PMID: 24152889.
46. Szarfarc S. C., de Cassana L. M., Fujimori E., et al. Relative effectiveness of iron bis-glycinate chelate (Ferrochel) and ferrous sulfate in the control of iron deficiency in pregnant women. Arch Latinoam Nutr. 2001; 51 (1 Suppl1): 42-47.
47. Fischer J. A. J., Cherian A. M., Bone J. N., Karakochuk C. D. The effects of oral ferrous bisglycinate supplementation on hemoglobin and ferritin concentrations in adults and children: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2023; 81 (8): 904-920. DOI: 10.1093/nutrit/nuac106. PMID: 36728680; PMCID: PMC10331582.
48. Bakirov B. A., Nagaev I. R., Donskov S. V. Nutritional correction of iron metabolism status in women of reproductive age: results of an open-label prospective post-registration study with active control in parallel groups. CardioSomatic. 2025; 1 (16). DOI: 10.17816/CS677071. (In Russ.)
Review
For citations:
Khovasova N.O., Naumov A.V. Prevention of iron deficiency and iron deficiency anemia in therapeutic practice. Lechaschi Vrach. 2025;1(11):92-99. (In Russ.) https://doi.org/10.51793/OS.2025.28.11.012
Views:
43
JATS XML
Email this article 
